Keep up with the latest news on SpayVac
BIOVAXYS and SPAYVAC-FOR-WILDLIFE INC EXPAND LICENSING AGREEMENT INTO COMMERCIAL AQUACULTURE
April 22, 2024 , Madison, WI. We’re excited to announce that our license agreement with BioVaxys (BVAXF U.S.: OTC) has been expanded to include commercial rights in aquaculture. This marks an important step forward as we build on successful proof-of-concept trials in farm-raised salmon and trout and prepare for dose-optimization studies in collaboration with our partners. https://www.prnewswire.com/news-releases/biovaxys-and-spayvac-for-wildlife-expand-license-agreement-into-commercial-aquaculture-302434429.html
SPAYVAC CONTINUES TO SCALE-UP VACCINE PRODUCTION CAPACITY AT OUR MADISON FACILITY
November 20, 2024 Madison, WI. SpayVac continues to gain traction. We are proud to announce that we have shipped a batch of vaccines from our Madison laboratory to Europe. This is a significant milestone as we've shipped to North America, Asia and Europe from our Madison location this year. PRN news wire link: https://www.prnewswire.com/news-releases/biovaxys-partner-spayvac-for-wildlife-inc-scales-up-vaccine-production-capacity-302311055.html
CEO CORNER VIDEO ABOUT SPAYVAC
September 05, 2024 Madison, WI. SpayVac-for-Wildlife, Inc. ("SpayVac") CEO, Tom D'Orazio discusses where the company is, how the product works, and the abundant opportunities and needs for their unique product.
SPAYVAC FOR WILDLIFE ANNOUNCES COMPLETION OF RESEARCH AND PRODUCTION FACILITY IN MADISON, WIS
August 19, 2024 Madison, WI. SpayVac-for-Wildlife, Inc. ("SpayVac") announces research and production laboratory facility in Madison, WI is now up and running and producing vaccine.
https://finance.yahoo.com/news/spayvac-wildlife-inc-announces-completion-120000989.html
LAUNCH OF TRIAL TO TEST SPAYVAC pZP VACCINE IN ASIAN ELEPHANTS
July 17,2024 Madison, WI. SpayVac will be used in a trial in Thailand on Asian Elephants (Elephas Maximus). The study will be conducted by the Elephant and Wildlife Clinic, Faculty of Veterinary.Medicine, at Chiang Mai University in Thailand. Please follow the link to learn more details about the trial.
LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY
April 10, 2024 Madison, WI. SpayVac-for-Wildlife, Inc. ("SpayVac") has partnered with a world leader in the aquaculture space to field test single-injection, long-lasting immuno-contraceptive vaccines in farmed rainbow trout. To learn more about the trial, there is a link to the entire release.